ABN AMRO in €220m food deal
Swiss pharmaceutical company Norvatis has sold a dietary and slimming products business to ABN AMRO Capital for €220m.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
Swiss pharmaceutical company Norvatis has sold a dietary and slimming products business to ABN AMRO Capital for €220m.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination